Geode Capital Management’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $21.7M | Sell |
|
|||||
|
2025
Q2 | $15M | Sell |
|
|||||
|
2025
Q1 | $8.64M | Buy |
|
|||||
|
2024
Q4 | $11.5M | Buy |
|
|||||
|
2024
Q3 | $9.58M | Buy |
|
|||||
|
2024
Q2 | $8.98M | Buy |
|
|||||
|
2024
Q1 | $17.2M | Buy |
|
|||||
|
2023
Q4 | $15.8M | Buy |
|
|||||
|
2023
Q3 | $4.28M | Buy |
|
|||||
|
2023
Q2 | $4.37M | Buy |
|
|||||
|
2023
Q1 | $1.42M | Buy |
|
|||||
|
2022
Q4 | $1.58M | Buy |
|
|||||
|
2022
Q3 | $3.56M | Sell |
|
|||||
|
2022
Q2 | $3.55M | Buy |
|
|||||
|
2022
Q1 | $5.19M | Buy |
|
|||||
|
2021
Q4 | $4.3M | Buy |
|
|||||
|
2021
Q3 | $3.59M | Buy |
|
|||||
|
2021
Q2 | $2.99M | Buy |
|
|||||
|
2021
Q1 | $1.5M | Buy |
|
|||||
|
2020
Q4 | $384K | Buy |
|
|||||
|
2020
Q3 | $269K | Hold |
|
|||||
|
2020
Q2 | $393K | Sell |
|
|||||
|
2020
Q1 | $911K | Buy |
|
|||||
|
2019
Q4 | $1.27M | Buy |
|
|||||
|
2019
Q3 | $1.43M | Buy |
|
|||||
|
2019
Q2 | $1.24M | Buy |
|
|||||
|
2019
Q1 | $775K | Buy |
|
|||||
|
2018
Q4 | $789K | Buy |
|
|||||
|
2018
Q3 | $1.12M | Buy |
|
|||||
|
2018
Q2 | $590K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $259K | Buy |
|
|||||
|
2017
Q3 | $164K | Hold |
|
|||||
|
2017
Q2 | $235K | Sell |
|
|||||
|
2017
Q1 | $246K | Buy |
|
|||||
|
2016
Q4 | $243K | Buy |
|
|||||
|
2016
Q3 | $426K | Buy |
|
|||||
|
2016
Q2 | $400K | Hold |
|
|||||
|
2016
Q1 | $379 | Buy |
|
|||||
|
2015
Q4 | $578K | Buy |
|
|||||
|
2015
Q3 | $436K | Buy |
|
|||||
|
2015
Q2 | $435K | Hold |
|
|||||
|
2015
Q1 | $456K | Buy |
|
|||||
|
2014
Q4 | $455K | Hold |
|
|||||
|
2014
Q3 | $490K | Hold |
|
|||||
|
2014
Q2 | $481K | Hold |
|
|||||
|
2014
Q1 | $454K | Buy |
|
|||||
|
2013
Q4 | $367K | Hold |
|
|||||
|
2013
Q3 | $380K | Hold |
|
|||||
|
2013
Q2 | $358K | Buy |
|